QR Kodea

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative diseases; including wet age-related macular degeneration (w-AMD) and diabetic macular edema (DME). Despite the important clinical achievements...

Deskribapen osoa

Gorde:
Egile Nagusiak: Lorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò, Marion R. Munk
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2023-05-01
Saila:Pharmaceutics
Gaiak:
faricimab
anti-VEGF drugs
intravitreal injections
ang/tie
ang2
angiogenesis
Sarrera elektronikoa:https://www.mdpi.com/1999-4923/15/5/1413
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak